To investigate whether XIAP expression level might serve as a biomarker predicting responsiveness to TRAIL receptor-activating agonistic molecules in general, we correlated semi-quantitative XIAP protein expression level with IZI1551 responsiveness in five different mutBRAF melanoma cell lines. The gene discussed is XIAP; the disease is melanoma.